A bovine viral diarrhea virus (BVDV-C) was isolated from swine tissue culture cells used to attenuate the transmissible gastroenteritis virus (TGEV) after 68 passes. Piglets given a pure culture of BVDV-C developed clinical signs similar to those of a mild TGEV infection and recovered by 10 days postexposure. Villous blunting and fusion was observed in the small intestine, and a lymphocyte depletion was observed in Peyer's patches in the ileum. Piglets given a combination of BVDV-C and attenuated TGEV developed clinical signs similar to those of a virulent TGEV infection and were euthanized. The combined infection induced a generalized lymphocyte depletion throughout the lymphatic system and villous atrophy in the intestinal tract. Piglets exposed to a another type I strain of BVDV (NY-1) either alone or in combination with the attenuated TGEV had mild clinical signs similar to those of a TGEV infection. Moderate villous atrophy in the ileum and a lymphocyte depletion in the mesenteric lymph node were observed in these piglets postmortem. The data indicate a potential problem for diagnostic laboratories in relation to a diagnosis of virulent TGEV infections and in the field for young piglets exposed to a BVDV-contaminated TGEV vaccine.
The transmissible gastroenteritis virus (TGEV) is a member of the Coronaviridae family of viruses. Coronaviruses are pleomorphic enveloped viruses with a nonsegmented positive-stranded RNA genome. 18 The mammalian coronaviruses are divided into 2 serologic groups. 15 Members of group I include canine coronavirus, feline enteric coronavirus, feline infectious peritonitis virus, human coronavirus 229E, porcine respiratory coronavirus, and TGEV. The group I viruses are antigenically related, but they exhibit a strong host specificity. TGEV infects swine of all ages, producing an economically important disease. 13 The severity of the disease is inversely related to the age of the pigs at the time of their exposure and to the virulence of the virus. Animals Ͻ10 days of age exposed to a virulent virus usually die within 7 days, whereas those 10-21 days of age exhibit clinical signs of a severe infection and about 50% die. 17 Sows and pigs Ͼ3 weeks of age usually have a milder response, with loss of appetite and diarrhea for 1-2 days being common, although vomiting, elevated temperatures, and death have also been observed. Producers attempt to control the disease by vaccination with modified-live virus vaccines for TGEV. These vaccines are produced in cell cultures supplemented with fetal bovine serum (FBS). 8 Before the FBS is used in cell cultures, it is screened for contaminating agents and toxic substances. Because the screening procedures for the bovine viral diarrhea/mucosal disease virus (BVDV) are not 100% efficient, some contaminated lots of sera are subsequently used in cell cultures. 3 Pigs are also susceptible to an infection with BVDV by direct or indirect contact with ruminants, 4, 14, 20 by experimental infection, 12, 19, 21 and by exposure to contaminated vaccines. 10, 23 Enhanced infections have been reported in animals coinfected with BVDV and other viral or bacterial agents. 2, 25 Experimental inoculations of swine with ruminant BVDVs have been inconclusive as to their effect and ability to induce clinical disease. 4, 14, 20 Serial passage of the Miller 3 TGEV in swine testicular (ST) cells did not reduce the virulence of the virus for young piglets. After 68 passes, 3-day-old piglets exposed to the virus developed clinical signs of a virulent TGEV infection. Near the end of the virus passes, several lots of FBS in the central media supply store were determined to be contaminated with a BVDV. Because the FBS used in these cell cultures originated from this source, the cell line used for the passage of TGEV was also contaminated. Thus, the results of virulence evaluation of the serially passed TGEV would be questionable because of the BVDV contaminant.
The purpose of this study was to determine the virulence of a TGEV passed multiple times in a swine cell culture system, to assess the safety of an attenuated TGEV in piglets coinfected with BVDV, and to determine the pathogenicity of BVDV adapted to grow in swine cells. 
Materials and methods
Cells and viruses. The McClurkin (ST) cell line was used for propagation and titration of TGEV. 11 A bovine turbinate (BT) cell line was used for propagation and titration of the BVDV. 7 The BT cell line is nonpermissive for TGEV. The Miller 3 strain of TGEV was used throughout this study. 5 This isolate was free of extraneous viral, bacterial, and toxic agents as predetermined by cell culture passage and a reverse transcriptase polymerase chain reaction (RT-PCR) procedure. 24 Initially, the virulent TGEV was passed 70 times in ST cells, and its virulence was checked after every fifth pass. After BVDV was identified in samples of the first TGEV passage, a second passage of the virulent TGEV series was initiated using the original Miller 3 virus, and it was also passed 70 times in the ST cells. A BVDV was isolated on BT cells from the 68th pass of the first TGEV passage. This virus was classified as a type I strain and designated BVDV-C. The NY-1 strain of BVDV was used for comparative purposes because of its similarity to the BVDV-C ( Fig. 1 ). The NY-1 strain had never been passed in swine cells. The history of the NY-1 strain has been previously reported. 9 Purity of each virus was confirmed by passage in cell culture, immunoperoxidase staining, and RT-PCR analysis.
Experimental design. All animal experiments were conducted in a laboratory certified by the Association for Assessment and Accreditation of Laboratory Animal Care International. Because 2 independent cell passes were made with TGEV, it was necessary to evaluate each pass for virulence in young piglets. For both evaluations, 60 caesarianderived colostrum-deprived (CDCD) piglets from sows seronegative for TGEV antibodies by virus neutralization (VN) were obtained from the Animal Resources Unit of the National Animal Disease Center (Ames, IA). The piglets were housed in Plexiglas isolators and feed a sow's milk replacer 4 times daily. CDCD piglets were selected over conventional piglets because they are better indicators of the virulence of TGEV. To determine virulence of the first TGEV passed multiple times in ST cell culture, 36 3-day-old piglets were randomly divided into 12 groups, and each piglet was given 5 ml of cell culture fluids containing 1 ϫ 10 6 plaque-forming units (pfu) of TGEV from the 15th to the 70th serial pass via stomach tube; 6 piglets were held as controls. After exposure, all piglets were observed 4 times daily for clinical signs of infection. Piglets exhibiting clinical signs of a virulent TGEV infection (vomiting, diarrhea, fever, inappetence, dehydration, and rough hair coat) were euthanized, and a portion of the small intestine was removed for virus isolation. Confirmation of a TGEV isolate was by VN and indirect fluorescent antibody staining (IFA) with a monoclonal antibody directed against the site A epitope.
To determine virulence and pathogenicity of the BVDVfree TGEV viral pass samples, 18 3-day-old piglets were randomly divided into 6 groups, and each piglet was given 5 ml of cell culture fluids by stomach tube. Three pigs were given 1 ϫ 10 6 pfu of TGEV 68th pass, 3 pigs were given 1 ϫ 10 6 pfu of BVDV NY-1, 3 pigs were given 1 ϫ 10 6 pfu of BVDV-C, 3 pigs were given TGEV-68/BVDV NY-1, 3 pigs were given TGEV-68/BVDV-C, and 3 pigs were given placebo fluids and held as controls. The piglets were observed four times daily for clinical signs of infection. Those exhibiting signs of a TGEV infection were euthanized, and various samples were collected for pathologic examination and virus isolation. Virus isolations were attempted on ST and BT cells. The RT-PCR procedure was performed for all samples to determine presence of TGEV or BVDV. Viruses isolated on ST cell cultures were identified by VN and IFA and those isolated on BT cells were identified by RT-PCR and immunoperoxidase staining.
RT-PCR. The RT-PCR procedure and primers used with TGEV and BVDV viruses have been described previously. 16, 24 TGEV primers were designed to amplify a 637-bp fragment on the spike gene of the Miller 3 TGEV. The BVDV primers were designed to amplify a 280-bp fragment in the highly conserved 5Ј untranslated region of the genome. The 280-bp fragments amplified from the BVDV-C virus used for inoculation and from the BVDV-C virus isolated from infected piglets were sequenced and compared as previously described. 16 
Results
In vivo results indicated that the first attempt to attenuate the Miller 3 TGEV was not successful because it did not reduced the virulence of the virus for 3-dayold piglets. Thirty-one of 36 piglets given TGEV-68th pass developed acute clinical signs of a virulent infection (diarrhea, inappetence, rough hair coat, gaunt, dehydration) and were euthanized 5-9 days postexposure (PE). The remaining 5 piglets (from serial pass 15 to pass 65) had milder clinical signs and slowly recovered. The control piglets remained free of clinical signs, and no significant lesions were observed postmortem. In a retrospective study using RT-PCR, none of the first 15 passes contained BVDV; however, every pass of TGEV after the 15th (16th to 70th) contained BVDV. The BVDV-C was isolated on BT cells from samples of TGEV after it had been passed 68 times. The BVDV-C was introduced into TGEV by passage in BVDV-contaminated ST cell cultures. Based on direct sequence analysis, the BVDV-C was classified as a noncytopathogenic type I virus similar to BVDV strain NY-1 ( Fig. 1) .
Virulence evaluation results of the second TGEV virus pass varied from the first pass results. All of the control piglets remained free of clinical signs throughout a 10 day observation period. One control piglet was euthanized for examination and virus isolation. No significant lesions were observed in any of the tissue samples examined. Virus was not identified by RT-PCR or isolated from any sample by 3 blind passes in ST and BT cell cultures.
Two of the pigs given BVDV NY-1 developed transient diarrhea and were off feed for 2 feedings before making uneventful recoveries. Clinical signs in the third pig indicated a moderate infection with persistent diarrhea for 3 days, and the piglet was off feed and sluggish for 2 days. By 8 days PE, the piglet was free of clinical signs and made an uneventful recovery. Histologic examination of tissues samples collected from this piglet at 10 days PE failed to identify any significant lesions ( Fig. 4 ). Neither TGEV nor BVDV was identified in any tissue sample by cell culture or RT-PCR procedures.
Piglets exposed to the 68th cell culture pass of BVDV-free TGEV developed mild to moderate clinical signs of a TGEV infection. These piglets developed diarrhea, were off their feed and sluggish for 1-3 days, and then recovered uneventfully, indicating a mild infection. None of the pigs required euthanasia, although 1 pig was necropsied. Examination of the small intestine revealed diffuse moderate to severe villous blunting and fusion with multifocal erosion of villous apices (Fig. 4) . No specific lesions were observed in the remaining tissue samples. TGEV was isolated in cell culture from tissue samples from the small intestine.
Two of the piglets exposed to TGEV-68/BVDV NY-1 developed a pronounced diarrhea and were off feed for 1-4 days and then recovered without any adverse effects. The third pig developed acute clinical signs of a virulent TGEV infection (profuse diarrhea, off feed, dehydrated, and weak) and was euthanized 6 days PE. There was segmental blunting and fusion of villi in the small intestine, with less severe mucosal lesions present in the ileum. In addition, there were multifocal erosions of duodenal villous apices and moderate lymphoplasmacytic infiltrates in the lamina propria of the duodenum and jejunum. In the ileum, lymphocyte depletion in Peyer's patches was characterized by hypocellularity and a large proportion of pyknotic cells. TGEV was isolated from the small intestine. Attempts to isolate BVDV from the tissue samples and intestinal content were unsuccessful.
Pigs given BVDV-C virus developed moderate to severe clinical signs of a virulent TGEV infection, which included profuse diarrhea and inappetence. The animals were sluggish, gaunt, and dehydrated. One pig was euthanized at 4 days PE, 1 pig was euthanized at 6 days PE, and the third pig was euthanized at 10 days PE, and tissue samples were collected at postmortem examination. Histologic examination of the intestinal samples revealed marked, diffuse villous blunting and fusion with multifocal erosions of villous apices in the duodenum, jejunum, and ileum. Infiltrates of moderate numbers of lymphocytes and plasmacytes were present in the lamina propria. There was a slight increase in the number of neutrophils in the lamina propria with a scant amount of neutrophilic exudate subjacent to areas of epithelial erosion (Fig. 4a ). Peyer's patches were attenuated and had moderate numbers of pyknotic cells. Attempts to isolate TGEV and BVDV from samples of the small intestine were unsuccessful. With the RT-PCR procedure, 280-bp and 637-bp fragments were amplified from the small intestine tissue samples using BVDV-and TGEV-specific primers, respectively, indicating a dual infection (Fig. 2) . The sequence of the amplicon generated from these tissues using BVDV-specific primers (184 bp) was identical to that of the BVDV-C virus used in the inoculum (Fig. 3) .
Piglets receiving TGEV-68/BVDV-C developed clinical signs typical of a virulent TGEV infection. The severity of the clinical signs required euthanasia of the piglets. One pig was euthanized at 4 days PE, 1 was euthanized at 5 days PE, and the third was euthanized at 7 days PE, and tissue samples were collected at postmortem examination. The piglet euthanized at 4 days PE was dehydrated and gaunt, had diarrhea, and was uncoordinated. The majority of the small intestine was distended with fluid and gas. The intestinal wall was thin and translucent. Histologic examination revealed diffuse villous atrophy and fusion, with multifocal erosion of villar apices. In addition, there was diffuse, marked congestion of the mucosa and sub- mucosa. Segmentally, moderate numbers of pyknotic cells were present in the superficial lamina propria. There was a moderate amount of lumenal exudate composed of cell debris admixed with mucus. Additional changes in the ileum included multifocal hemorrhages in the lamina propria and neutrophilic infiltrates associated with focal necrosis of the upper onethird of the mucosa. Peyer's patches were inconspicuous and contained many pyknotic lymphocytes. Lymphocyte depletion was present in many organs. There was moderate lymphocyte depletion in the mesenteric lymph node, with many pyknotic follicular lymphocytes. There was diffuse, marked cortical lymphoid depletion in the thymus. Splenic periarterioloar lymphoid sheaths were greatly attenuated ( Fig. 5 ). TGEV was isolated from the small intestine of 2 of the 3 piglets. With the RT-PCR procedure, 280-bp and 637-bp fragments were amplified from the small intestine tissue samples using BVDV-and TGEV-specific primers, respectively (Fig. 2) . The sequence of the amplicon generated from these tissues using BVDV-specific primers (184 bp) was identical to that of the BVDV-C virus used in the inoculum (Fig. 3 ).
Discussion
Cell cultures used to attenuate TGEV were contaminated with BVDV, and the presence of both viruses resulted in clinical disease and lesions that were similar to those of a virulent TGEV infection. Coinfection with both viruses was more severe than infection with either virus alone. This synergistic activity not only occurred with the BVDV-C isolated from the tissue culture medium but also with another isolate, BVDV NY-1. These results demonstrate the dangers of using a BVDV-contaminated tissue culture system to attenuate TGEV and the potential danger of using an attenuated TGEV vaccine in pigs infected with BVDV. 22 These results are also important in the emerging field of synergistic viral pathogenesis involving BVDV in many animal species.
Because the potential for a BVDV/TGEV coinfection exists in the field through vaccination or direct animal contact, the effect each virus produced in piglets was evaluated. When a traditional type I BVDV (NY-1) was given to piglets, they had limited clinical signs. In contrast, 2 of the 3 piglets exposed to the ST cell culture-adapted BVDV-C virus developed clinical signs of a more severe infection. One piglet was euthanized 7 days PE. However, histologic examination of tissue samples from 2 of the 3 NY-1 piglets and 2 of the 3 BVDV-C piglets indicated moderate villous blunting and fusion throughout the intestinal tract and depletion of lymphocytes in Peyer's patches. No other lesions were observed. The third piglet given BVDV-C had severe villous atrophy throughout the intestinal tract and nearly complete lymphocyte depletion in Peyer's patches, mesenteric lymph nodes, thymus, and spleen. The 2 type I viruses are phylogenetically closely related but differ in that BVDV-C was passaged in ST cells for approximately 1 year whereas the NY-1 strain had never been cultured in the ST cells. The sequence of the 5Ј untranslated region for both viruses had greater than a 97% homology ( Fig. 1) . However, the results of this experiment indicate that a type I BVDV strain can be adapted to grow in ST cells and may then produce moderate to severe clinical signs in young piglets.
Similar differences were observed between the 2 groups of pigs that received the BVDV/TGEV combinations. The differences were directly related to the strain of BVDV and not that of TGEV. Two of the 3 piglets inoculated with TGEV-68/BVDV NY-1 had mild clinical signs before making uneventful recoveries. One of the piglets required euthanasia 6 days PE because clinical signs indicated a potentially fatal TGEV infection. Examination of tissue samples from this pig indicated that most of the changes (translucent cell walls and villous atrophy) were attributed to TGEV. In contrast, the piglets given TGEV-68/BVDV-C had acute clinical signs, and none of the animals survived for 10 days. The clinical signs were indicative of a classical TGEV infection. If tissue specimens from these animals had been submitted to a diagnostic laboratory for identification, they would probably have been diagnosed as having a TGEV infection. This opinion would be based on clinical signs observed in the piglets and lesions observed in the small intestine (translucent cell wall and villous atrophy with blunting and fusion), and an impression smear would be positive in an IFA procedure with TGEV antibodies, and a cytopathic TGEV would be isolated from homogenized intestinal samples. Unless the laboratory rou- tinely screened for BVDV, the diagnosis would be a virulent TGEV infection. Both groups of pigs receiving the combination TGEV/BVDV had a depletion of lymphocytes in Peyer's patches. In ruminants, BVDV has been associated with necrotic lesions and destruction of cells and tissues within the lymphoid elements. 1, 6 Based on the depletion, it appears both of the BVDVs were capable of destroying the lymphocytes. Because BVDV-C was adapted to grow in swine cells, it may have been able to spread throughout the entire lymphatic system, resulting in the widespread depletion. The NY-1 strain apparently did not spread from the primary site of infection in the small intestine. The effect of adapting the NY-1 strain to grow in ST cells and then infecting swine was not tested. The severity of the combined infection, BVDV-C and TGEV, could be attributed to the destruction of the lymphocytes by the BVDV-C and destruction of the villous epithelial cells by TGEV. This coinfection was fatal for the young pigs. The combination was not tested in older swine or conventional piglets nursing normal sows.
Most commercial modified-live virus vaccines for swine are produced in cell culture systems that utilize FBS in the media for cell growth (10%) and production (1-2%). Purity of tissue culture cell lines used in diagnostic laboratories, commercial biological companies, and biological research laboratories must be confirmed on a regular basis. The most common contaminant identified in these cell lines is BVDV. 3 Although it is time consuming, the immunoperoxidase staining procedure is the most sensitive and commonly used method to detect BVDV. 7 However, a rapid and sensitive RT-PCR procedure for identifying BVDV was adapted for use with a cell culture system. 16 After initiation of the RT-PCR screening procedure, the cell lines have remained free of BVDV. The quality control section of a commercial company is responsible for certifying purity of all components used in the production of vaccines and the product sold for use in the field. Depending on the procedures used to certify purity, it is very likely that BVDV-contaminated vaccines could be missed and thus sold to pig producers. Most vaccines are given to the sow, although some companies have suggested giving the vaccine to young pigs. Although the effect of exposing the sow to a TGEV vaccine contaminated with BVDV is unknown, the effect of giving the vaccine to the young piglets could be lethal. This study emphasizes the importance of maintaining the purity of swine vaccines and the potential need to screen field cases identified as a virulent TGEV infection for BVDV.
Previous investigators have demonstrated that infections with a bovine coronavirus (BCV), Salmonella sp., or bovine respiratory syncytial virus (BRSV) (unpublished data) were aggravated by concurrent BVDV infection. 2, 25 The results in this study suggest that a simultaneous infection with BVDV may indeed intensify the effects of another infectious agent. The etiologic relationship of the 2 agents should be considered during outbreaks of bovine respiratory disease, including BRSV infection and salmonellosis. A similar picture was observed with TGEV and BVDV. Two coronaviruses (TGEV and BCV) have demonstrated an enhanced infectivity when combined with the BVDV; it is unknown whether any of the other coronaviruses also exhibit an enhanced infection in the presence of BVDV.
